Management - Page 12 of 50 - Express Pharma

The US FDA approval of Trastuzumab is a huge milestone for Biocon

Can Indian Pharma Inc find its lost mojo?

Policy experiences of 2017 for pharma sector

Towards a healthier Bharat

Is it too early to talk of global health?

The global negative pressure wound therapy market set to reach $1.3 bn in 2024

Crohn’s Disease diagnosed incident cases set to increase in the 7MM to 2026

Affluent market, medical tourism to steer best-in line drug delivery devices in India

New diabetes therapeutics to steal ground from insulin therapies: GBI Research

Consolidated FDI policy 2017 – Implications on pharmaceuticals and healthcare sector